JP Morgan Maintains Overweight on Aptiv, Raises Price Target to $113

Benzinga · 10/21 12:31
JP Morgan analyst Ryan Brinkman maintains Aptiv (NYSE:APTV) with a Overweight and raises the price target from $107 to $113.